Most new drugs keep on with the revenue trajectory set at start. About 70 p.c of products that miss expectations at launch proceed doing so in subsequent many years, and all around eighty per cent of products that meet up with or conquer expectations continue on to take action afterward. The situation analyze (see sidebar, “Medical superiority